Lactose (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 7:31 pm

Market Cap	134 Cr.
Current Price	95.0
High / Low	247/84.3
Stock P/E	26.0
Book Value	41.7
Dividend Yield	0.00 %
ROCE	12.9 %
ROE	9.75 %
Face Value	10.0
PEG Ratio	0.48

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Lactose (India) Ltd

Competitors of Lactose (India) Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Lactose (India) Ltd	134 Cr.	95.0	247/84.3	26.0	41.7	0.00 %	12.9 %	9.75 %	10.0
MPS Pharmaa Ltd	5.27 Cr.	2.76	4.33/2.50		0.57	0.00 %	9.79 %	59.0 %	10.0
Gujarat Themis Biosyn Ltd	2,663 Cr.	244	390/192	50.6	20.5	0.27 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	39.9 Cr.	53.8	94.9/44.5		8.73	0.00 %	41.5 %	14.4 %	10.0
Gujarat Inject (Kerala) Ltd	41.1 Cr.	28.0	29.1/13.1	40.3	6.83	0.00 %	13.5 %	11.0 %	10.0
Industry Average	18,354.98 Cr	1,129.60		88.53	194.54	0.32%	16.70%	15.22%	6.19

All Competitor Stocks of Lactose (India) Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	14.35	9.62	13.17	17.02	25.99	27.47	24.43	32.60	29.40	29.46	30.45	28.72	27.77
Expenses	8.85	7.34	10.82	14.29	21.99	23.70	21.04	26.88	23.28	23.88	25.44	25.75	24.36
Operating Profit	5.50	2.28	2.35	2.73	4.00	3.77	3.39	5.72	6.12	5.58	5.01	2.97	3.41
OPM %	38.33%	23.70%	17.84%	16.04%	15.39%	13.72%	13.88%	17.55%	20.82%	18.94%	16.45%	10.34%	12.28%
Other Income	0.30	0.23	0.20	0.16	0.14	0.28	0.26	0.28	0.31	0.22	0.30	0.56	0.37
Interest	1.23	1.24	1.31	1.55	1.84	1.55	1.31	1.21	1.17	1.26	1.37	1.64	1.84
Depreciation	1.19	1.16	1.17	1.17	1.19	1.19	1.20	1.20	1.63	1.31	1.33	1.35	1.39
Profit before tax	3.38	0.11	0.07	0.17	1.11	1.31	1.14	3.59	3.63	3.23	2.61	0.54	0.55
Tax %	23.96%	18.18%	-14.29%	11.76%	20.72%	26.72%	28.95%	27.02%	33.88%	29.72%	22.22%	59.26%	-18.18%
Net Profit	2.57	0.09	0.09	0.14	0.89	0.96	0.81	2.63	2.40	2.27	2.03	0.22	0.64
EPS in Rs	2.04	0.07	0.07	0.11	0.71	0.76	0.64	2.09	1.91	1.80	1.61	0.16	0.45

Last Updated: May 31, 2025, 5:30 am

Below is a detailed analysis of the quarterly data for Lactose (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 27.77 Cr.. The value appears to be declining and may need further review. It has decreased from 28.72 Cr. (Dec 2024) to 27.77 Cr., marking a decrease of 0.95 Cr..
For Expenses, as of Mar 2025, the value is 24.36 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.75 Cr. (Dec 2024) to 24.36 Cr., marking a decrease of 1.39 Cr..
For Operating Profit, as of Mar 2025, the value is 3.41 Cr.. The value appears strong and on an upward trend. It has increased from 2.97 Cr. (Dec 2024) to 3.41 Cr., marking an increase of 0.44 Cr..
For OPM %, as of Mar 2025, the value is 12.28%. The value appears strong and on an upward trend. It has increased from 10.34% (Dec 2024) to 12.28%, marking an increase of 1.94%.
For Other Income, as of Mar 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 0.56 Cr. (Dec 2024) to 0.37 Cr., marking a decrease of 0.19 Cr..
For Interest, as of Mar 2025, the value is 1.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.64 Cr. (Dec 2024) to 1.84 Cr., marking an increase of 0.20 Cr..
For Depreciation, as of Mar 2025, the value is 1.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.35 Cr. (Dec 2024) to 1.39 Cr., marking an increase of 0.04 Cr..
For Profit before tax, as of Mar 2025, the value is 0.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.54 Cr. (Dec 2024) to 0.55 Cr., marking an increase of 0.01 Cr..
For Tax %, as of Mar 2025, the value is -18.18%. The value appears to be improving (decreasing) as expected. It has decreased from 59.26% (Dec 2024) to -18.18%, marking a decrease of 77.44%.
For Net Profit, as of Mar 2025, the value is 0.64 Cr.. The value appears strong and on an upward trend. It has increased from 0.22 Cr. (Dec 2024) to 0.64 Cr., marking an increase of 0.42 Cr..
For EPS in Rs, as of Mar 2025, the value is 0.45. The value appears strong and on an upward trend. It has increased from 0.16 (Dec 2024) to 0.45, marking an increase of 0.29.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	46	22	24	34	36	31	41	40	35	46	66	114	118
Expenses	43	21	19	24	24	25	31	31	29	34	54	95	98
Operating Profit	3	1	5	10	11	6	10	9	6	12	11	19	20
OPM %	6%	5%	22%	30%	32%	18%	24%	23%	18%	27%	17%	17%	17%
Other Income	1	2	0	1	1	1	0	0	0	1	1	1	1
Interest	1	1	3	4	4	5	5	6	5	5	6	5	5
Depreciation	2	2	2	3	3	4	4	4	4	5	5	5	6
Profit before tax	1	0	1	4	4	-3	1	0	-3	3	1	10	10
Tax %	30%	60%	42%	28%	36%	-52%	33%	30%	-24%	23%	18%	30%
Net Profit	1	0	0	3	3	-1	1	0	-2	2	1	7	7
EPS in Rs	1.28	0.04	0.59	3.17	2.87	-1.32	0.71	0.07	-2.17	1.95	0.96	5.39	5.48
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2016-2017	2017-2018	2018-2019	2019-2020	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-100.00%	0.00%	-133.33%	200.00%	-100.00%	200.00%	-50.00%	600.00%
Change in YoY Net Profit Growth (%)	0.00%	100.00%	-133.33%	333.33%	-300.00%	300.00%	-250.00%	650.00%

Lactose (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	17%
5 Years:	24%
3 Years:	36%
TTM:	2%

Compounded Profit Growth
10 Years:	26%
5 Years:	136%
3 Years:	29%
TTM:	-24%

Stock Price CAGR
10 Years:	14%
5 Years:	39%
3 Years:	4%
1 Year:	-36%

Return on Equity
10 Years:	5%
5 Years:	6%
3 Years:	10%
Last Year:	10%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	8	8	8	9	10	10	10	10	11	13	13	13	13
Reserves	7	7	7	12	17	22	24	24	24	27	28	35	39
Borrowings	8	23	39	37	34	38	36	39	46	41	38	39	46
Other Liabilities	24	22	25	26	24	13	11	10	7	10	22	14	16
Total Liabilities	47	60	80	83	85	83	82	84	88	90	101	101	113
Fixed Assets	15	28	62	61	64	63	60	62	59	59	56	55	54
CWIP	11	15	1	1	1	0	1	0	4	0	0	0	1
Investments	1	1	1	0	0	0	0	0	1	1	0	0	0
Other Assets	20	16	15	21	20	19	20	22	25	30	45	46	58
Total Assets	47	60	80	83	85	83	82	84	88	90	101	101	113

Below is a detailed analysis of the balance sheet data for Lactose (India) Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
For Reserves, as of Sep 2024, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Mar 2024) to 39.00 Cr., marking an increase of 4.00 Cr..
For Borrowings, as of Sep 2024, the value is 46.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 39.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 7.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 2.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 113.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 101.00 Cr. (Mar 2024) to 113.00 Cr., marking an increase of 12.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Mar 2024) to 54.00 Cr., marking a decrease of 1.00 Cr..
For CWIP, as of Sep 2024, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 12.00 Cr..
For Total Assets, as of Sep 2024, the value is 113.00 Cr.. The value appears strong and on an upward trend. It has increased from 101.00 Cr. (Mar 2024) to 113.00 Cr., marking an increase of 12.00 Cr..

However, the Borrowings (46.00 Cr.) are higher than the Reserves (₹39.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	7	13	1	8	0	5	7	2	8	8	9
Cash from Investing Activity +	-21	-23	3	-5	-2	-2	-3	-6	-1	-1	-2
Cash from Financing Activity +	13	10	-5	-3	4	-5	-4	5	-8	-8	-6
Net Cash Flow	-1	-1	-0	-0	3	-2	1	1	-0	-1	1

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-5.00	-22.00	-34.00	-27.00	-23.00	-32.00	-26.00	-30.00	-40.00	-29.00	-27.00	-20.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	83	125	83	96	91	63	62	64	67	90	69	49
Inventory Days	47	69	129	344	440	456	384	471	587	343	344	119
Days Payable	119	308	273	340	559	330	242	202	153	195	275	59
Cash Conversion Cycle	11	-114	-61	100	-27	188	204	333	501	238	138	109
Working Capital Days	32	-20	-61	-33	-23	18	43	76	125	100	88	73
ROCE %	9%	-3%	8%	13%	15%	4%	9%	8%	3%	10%	9%	18%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoters	53.79%	53.79%	53.79%	53.79%	53.79%	53.77%	53.66%	53.65%	53.65%	53.65%	53.65%	53.65%
DIIs	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%	0.62%
Public	45.59%	45.59%	45.59%	45.59%	45.59%	45.62%	45.73%	45.72%	45.74%	45.73%	45.73%	45.74%
No. of Shareholders	15,777	15,943	15,940	15,902	15,898	15,950	16,088	16,245	16,630	16,998	17,115	17,082

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	5.39	0.96	2.10	-2.40	0.07
Diluted EPS (Rs.)	5.39	0.96	2.10	-2.40	0.07
Cash EPS (Rs.)	9.54	4.68	5.57	1.64	3.90
Book Value[Excl.RevalReserv]/Share (Rs.)	37.41	32.22	31.20	30.68	33.65
Book Value[Incl.RevalReserv]/Share (Rs.)	37.41	32.22	31.20	30.68	33.65
Revenue From Operations / Share (Rs.)	90.47	52.26	36.49	30.57	39.31
PBDIT / Share (Rs.)	15.98	9.61	10.20	5.71	9.38
PBIT / Share (Rs.)	11.84	5.89	6.58	1.90	5.55
PBT / Share (Rs.)	7.68	1.16	2.52	-2.86	0.09
Net Profit / Share (Rs.)	5.39	0.96	1.95	-2.17	0.07
PBDIT Margin (%)	17.66	18.38	27.95	18.69	23.87
PBIT Margin (%)	13.08	11.26	18.02	6.22	14.12
PBT Margin (%)	8.48	2.22	6.89	-9.35	0.24
Net Profit Margin (%)	5.96	1.83	5.33	-7.08	0.18
Return on Networth / Equity (%)	14.41	2.97	6.23	-7.06	0.21
Return on Capital Employeed (%)	19.78	9.85	10.99	2.83	7.87
Return On Assets (%)	6.73	1.18	2.71	-2.80	0.08
Long Term Debt / Equity (X)	0.51	0.81	0.87	1.12	0.98
Total Debt / Equity (X)	0.80	0.95	1.04	1.20	1.03
Asset Turnover Ratio (%)	1.12	0.68	0.51	0.40	0.48
Current Ratio (X)	1.40	1.41	1.53	1.69	1.73
Quick Ratio (X)	0.73	0.55	1.05	0.97	0.94
Inventory Turnover Ratio (X)	2.47	2.37	0.72	0.53	0.64
Interest Coverage Ratio (X)	3.84	2.03	2.51	1.20	1.72
Interest Coverage Ratio (Post Tax) (X)	2.30	1.20	1.48	0.54	1.01
Enterprise Value (Cr.)	211.83	93.28	114.35	69.83	50.44
EV / Net Operating Revenue (X)	1.86	1.42	2.49	2.00	1.26
EV / EBITDA (X)	10.53	7.71	8.91	10.68	5.28
MarketCap / Net Operating Revenue (X)	1.54	0.84	1.64	0.87	0.42
Price / BV (X)	3.73	1.37	1.92	0.87	0.49
Price / Net Operating Revenue (X)	1.54	0.84	1.64	0.87	0.42
EarningsYield	0.03	0.02	0.03	-0.08	0.00

After reviewing the key financial ratios for Lactose (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 5.39. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 5.39, marking an increase of 4.43.
For Diluted EPS (Rs.), as of Mar 24, the value is 5.39. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 5.39, marking an increase of 4.43.
For Cash EPS (Rs.), as of Mar 24, the value is 9.54. This value is within the healthy range. It has increased from 4.68 (Mar 23) to 9.54, marking an increase of 4.86.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 37.41. It has increased from 32.22 (Mar 23) to 37.41, marking an increase of 5.19.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 37.41. It has increased from 32.22 (Mar 23) to 37.41, marking an increase of 5.19.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 90.47. It has increased from 52.26 (Mar 23) to 90.47, marking an increase of 38.21.
For PBDIT / Share (Rs.), as of Mar 24, the value is 15.98. This value is within the healthy range. It has increased from 9.61 (Mar 23) to 15.98, marking an increase of 6.37.
For PBIT / Share (Rs.), as of Mar 24, the value is 11.84. This value is within the healthy range. It has increased from 5.89 (Mar 23) to 11.84, marking an increase of 5.95.
For PBT / Share (Rs.), as of Mar 24, the value is 7.68. This value is within the healthy range. It has increased from 1.16 (Mar 23) to 7.68, marking an increase of 6.52.
For Net Profit / Share (Rs.), as of Mar 24, the value is 5.39. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 5.39, marking an increase of 4.43.
For PBDIT Margin (%), as of Mar 24, the value is 17.66. This value is within the healthy range. It has decreased from 18.38 (Mar 23) to 17.66, marking a decrease of 0.72.
For PBIT Margin (%), as of Mar 24, the value is 13.08. This value is within the healthy range. It has increased from 11.26 (Mar 23) to 13.08, marking an increase of 1.82.
For PBT Margin (%), as of Mar 24, the value is 8.48. This value is below the healthy minimum of 10. It has increased from 2.22 (Mar 23) to 8.48, marking an increase of 6.26.
For Net Profit Margin (%), as of Mar 24, the value is 5.96. This value is within the healthy range. It has increased from 1.83 (Mar 23) to 5.96, marking an increase of 4.13.
For Return on Networth / Equity (%), as of Mar 24, the value is 14.41. This value is below the healthy minimum of 15. It has increased from 2.97 (Mar 23) to 14.41, marking an increase of 11.44.
For Return on Capital Employeed (%), as of Mar 24, the value is 19.78. This value is within the healthy range. It has increased from 9.85 (Mar 23) to 19.78, marking an increase of 9.93.
For Return On Assets (%), as of Mar 24, the value is 6.73. This value is within the healthy range. It has increased from 1.18 (Mar 23) to 6.73, marking an increase of 5.55.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.51. This value is within the healthy range. It has decreased from 0.81 (Mar 23) to 0.51, marking a decrease of 0.30.
For Total Debt / Equity (X), as of Mar 24, the value is 0.80. This value is within the healthy range. It has decreased from 0.95 (Mar 23) to 0.80, marking a decrease of 0.15.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.12. It has increased from 0.68 (Mar 23) to 1.12, marking an increase of 0.44.
For Current Ratio (X), as of Mar 24, the value is 1.40. This value is below the healthy minimum of 1.5. It has decreased from 1.41 (Mar 23) to 1.40, marking a decrease of 0.01.
For Quick Ratio (X), as of Mar 24, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 23) to 0.73, marking an increase of 0.18.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.47. This value is below the healthy minimum of 4. It has increased from 2.37 (Mar 23) to 2.47, marking an increase of 0.10.
For Interest Coverage Ratio (X), as of Mar 24, the value is 3.84. This value is within the healthy range. It has increased from 2.03 (Mar 23) to 3.84, marking an increase of 1.81.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.30. This value is below the healthy minimum of 3. It has increased from 1.20 (Mar 23) to 2.30, marking an increase of 1.10.
For Enterprise Value (Cr.), as of Mar 24, the value is 211.83. It has increased from 93.28 (Mar 23) to 211.83, marking an increase of 118.55.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.86. This value is within the healthy range. It has increased from 1.42 (Mar 23) to 1.86, marking an increase of 0.44.
For EV / EBITDA (X), as of Mar 24, the value is 10.53. This value is within the healthy range. It has increased from 7.71 (Mar 23) to 10.53, marking an increase of 2.82.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 0.84 (Mar 23) to 1.54, marking an increase of 0.70.
For Price / BV (X), as of Mar 24, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 1.37 (Mar 23) to 3.73, marking an increase of 2.36.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 0.84 (Mar 23) to 1.54, marking an increase of 0.70.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 23) to 0.03, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Lactose (India) Ltd as of June 1, 2025 is: 86.26

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, Lactose (India) Ltd is Overvalued by 9.20% compared to the current share price 95.00

Intrinsic Value of Lactose (India) Ltd as of June 1, 2025 is: 132.80

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, Lactose (India) Ltd is Undervalued by 39.79% compared to the current share price 95.00

Last 5 Year EPS CAGR: 53.96%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has shown consistent growth in sales (50.23 cr) and profit (2.23 cr) over the years.	The stock has a low average ROCE of 8.58%, which may not be favorable. The stock has a high average Working Capital Days of 34.83, which may not be favorable. The stock has a high average Cash Conversion Cycle of 135.00, which may not be favorable. The company has higher borrowings (35.69) compared to reserves (21.00), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Lactose (India) Ltd:
1. Net Profit Margin: 5.96%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 19.78% (Industry Average ROCE: 16.7%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 14.41% (Industry Average ROE: 15.22%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.3
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.73
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 26 (Industry average Stock P/E: 88.53)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.8
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Lactose (India) Ltd. is a Public Limited Listed company incorporated on 11/03/1991 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L15201GJ1991PLC015186 and registration number is 015186. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 113.89 Cr. and Equity Capital is Rs. 12.59 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	Survey No.5,6,7A, Village Poicha (Rania), Vadodra District Gujarat 391780	lil@lactoseindialimited.com http://www.lactoseindialimited.com

Management
Name	Position Held
Mr. Atul Maheshwari	Managing Director
Mrs. Sangita Maheshwari	WholeTime Director & CFO
Mr. Pramod Kalani	Ind. Non-Executive Director
Mr. G K Sarda	Ind. Non-Executive Director
Mr. Dhaval Jayant Soni	Ind. Non-Executive Director

FAQ

What is the intrinsic value of Lactose (India) Ltd?

Lactose (India) Ltd's intrinsic value (as of 31 May 2025) is ₹86.26 — 9.20% lower the current market price of 95.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 134 Cr. market cap, FY2025-2026 high/low of ₹247/84.3, reserves of 39 Cr, and liabilities of 113 Cr.

What is the Market Cap of Lactose (India) Ltd?

The Market Cap of Lactose (India) Ltd is 134 Cr..

What is the current Stock Price of Lactose (India) Ltd as on 31 May 2025?

The current stock price of Lactose (India) Ltd as on 31 May 2025 is 95.0.

What is the High / Low of Lactose (India) Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Lactose (India) Ltd stocks is ₹247/84.3.

What is the Stock P/E of Lactose (India) Ltd?

The Stock P/E of Lactose (India) Ltd is 26.0.

What is the Book Value of Lactose (India) Ltd?

The Book Value of Lactose (India) Ltd is 41.7.

What is the Dividend Yield of Lactose (India) Ltd?

The Dividend Yield of Lactose (India) Ltd is 0.00 %.

What is the ROCE of Lactose (India) Ltd?

The ROCE of Lactose (India) Ltd is 12.9 %.

What is the ROE of Lactose (India) Ltd?

The ROE of Lactose (India) Ltd is 9.75 %.

What is the Face Value of Lactose (India) Ltd?

The Face Value of Lactose (India) Ltd is 10.0.